These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37457723)

  • 1. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer.
    Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR
    Front Immunol; 2023; 14():1209572. PubMed ID: 37457723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE
    Thumkeo D; Punyawatthananukool S; Prasongtanakij S; Matsuura R; Arima K; Nie H; Yamamoto R; Aoyama N; Hamaguchi H; Sugahara S; Takeda S; Charoensawan V; Tanaka A; Sakaguchi S; Narumiya S
    Cell Rep; 2022 Jun; 39(10):110914. PubMed ID: 35675777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-intrinsic prostaglandin E
    Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
    J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4/PKA-mediated mechanism.
    Schmidt A; Sinnett-Smith J; Young S; Chang HH; Hines OJ; Dawson DW; Rozengurt E; Eibl G
    Surgery; 2017 Jun; 161(6):1570-1578. PubMed ID: 28222855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
    Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
    Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
    Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.
    Holt DM; Ma X; Kundu N; Collin PD; Fulton AM
    J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses.
    Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM
    Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists.
    Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
    Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
    Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic regulation by prostaglandin E
    Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
    Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils.
    Lavoie JC; Simard M; Kalkan H; Rakotoarivelo V; Huot S; Di Marzo V; Côté A; Pouliot M; Flamand N
    J Leukoc Biol; 2024 May; 115(6):1183-1189. PubMed ID: 38345417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
    Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E
    Ohkura N; Yoshiba K; Yoshiba N; Oda Y; Edanami N; Ohshima H; Takenaka S; Okiji T; Noiri Y
    J Endod; 2023 Apr; 49(4):410-418. PubMed ID: 36758673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
    Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
    Cells; 2020 May; 9(5):. PubMed ID: 32438662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E
    Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
    Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.